Sommers BD, Kesselheim AS - New England Journal of Medicine
The authors discuss Massachusetts’ waiver proposal to shift low-income adults from Medicaid to private marketplace plans, examining whether this approach would improve care or simply shift costs, while also discussing the state’s innovative drug pricing provisions.
VIEW SOURCE
Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics
Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine
Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open